Search
for
Sort by
Research 31–60 of 137
- Monocyclic Aromatic Compounds
- Sesamin alleviates androgenetic alopecia by targeting the AR MAPK Wnt axis
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- The Bis(1,2,3,4-tetrahydroisoquinoline) Alkaloids Cepharanthine and Berbamine Are Ligands of SK Channels
- Drug Repositioning: New Opportunities for Older Drugs
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Sulfatase inhibitors: a patent review
- Recent advances in oxasteroids chemistry
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- 4-O-Methylhonokiol: A lesser-known neolignan from Magnolia species with diverse and promising pharmacological properties
- Vesicular Carriers for Follicular Drug Delivery
- Pharmacognostical and Phytochemical Study of Hibiscus rosasinensis Linn.
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- In-silico screening of potential anti-androgenic and anti-estrogenic phytocompounds from Saraca asoca for polycystic ovary syndrome treatment
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Hormone Blocking Anticancer Drugs
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Pharmacology of anabolic steroids
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
- An investigation of crosstalk between Wnt/β-catenin and transforming growth factor-β signaling in androgenetic alopecia
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels